[1] Constantinou MA, Theocharis SE, Mikros E. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats. Toxicol Appl Pharmacol. 2007;218(1): 11-19.
[2] Boyer-Diaz Z, Aristu-Zabalza P, Andrés-Rozas M, Robert C, Ortega-Ribera M, Fernández-Iglesias A, et al. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease. J Hepatol. 2020;8278(20): 33832-33840.
[3] Marciniak S, Wnorowski A, Smolińska K, Walczyna B, Turski W, Kocki T, et al. Kynurenic Acid Protects against Thioacetamide-Induced Liver Injury in Rats. Anal Cell Pathol (Amsterdam). 2018; 28(9): 1-11.
[4] Zargar S, Alonazi M, Rizwana H, Wani TA. Resveratrol Reverses Thioacetamide-Induced Renal Assault with respect to Oxidative Stress, Renal Function, DNA Damage, and Cytokine Release in Wistar Rats. Oxidative Medicine and Cellular Longevity. 2019; 27 (2): 1-8.
[5] Caballero ME, Berlanga J, Ramirez D, Lopez-Saura P, Gozalez R, Floyd DN, et al. Epidermal growth factor reduces multiorgan failure induced by thioacetamide. 2001;48(1): 34-40.
[6] Avraham Y, Grigoriadis NC, Magen I, Poutahidis T, Vorobiav L, Zolotarev O, et al. Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice. British Journal of Pharmacology. 2009;158(3): 896-906.
[7] Latha SM, Pai MR, Pai PK. Thioacetamide toxicity and the lung: histological analysis. Indian Journal of Physiology and Pharmacology. 2003;47(4): 476-478.
[8] Kadir FA, Kassim NM, Abdulla MA, Yehye WA. Effect of oral administration of ethanolic extract of Vitex negundo on thioacetamide-induced nephrotoxicity in rats. BMC Complementary Alternative Medicine. 2013;13(1): 294-301.
[9] Gao W, Li HY, Wang LX, Hao LJ, Gao JL, Zheng RJ, et al. Protective effect of omeprazole on gastric mucosal of cirrhotic portal hypertension rats. Asian Pacific Journal of Tropical Medicine. 2014;7(5): 402-406.
[10] Lin D, Wu X, Ji X, Zhang Q, Lin Y, Chen W, et al. A novel canine model of portal vein stenosis plus thioacetamide administration-induced cirrhotic portal hypertension with hypersplenism. Cell Biochem Biophys. 2012;62(1): 245-255.
[11] El-Marasy SA, El Awdan SA, Abd-Elsalam RM. Protective role of chrysin on thioacetamide-induced hepatic encephalopathy in rats. Chem Biol Interact. 2019;299(1): 111-119.
[12] Lassila V, Virtanen P. Influence of experimental liver injury on rat blood and alveolar bone under stress. Acta Anat (Basel). 1984;118(2): 116-121.
[13] Virtanen P, Lassila V. Influence of thioacetamide-provoked liver injury on female rat blood and alveolar bone under stress. Acta Anat (Basel). 1986;127(4): 285-289.
[14] Nakano A, Kanda T, Abe H. Bone changes and mineral metabolism disorders in rats with experimental liver cirrhosis. J Gastroenterol Hepatol. 1996;11(12): 1143-1154.
[15] Batoon L, Millard SM, Raggatt LJ, Pettit AR. Osteomacs and Bone Regeneration. Curr Osteoporos Rep. 2017;15(4): 385-395.
[16] Zeng X, Zhang Y, Wang S, Wang K, Tao L, Zou M, et al. Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCγ1-Ca2+-NFATc1 signaling pathway and prevents ovariectomy-induced bone loss. Biochem Pharmacol. 2017;124: 57-68.
[17] Ramchand SK, Seeman E. The Influence of Cortical Porosity on the Strength of Bone During Growth and Advancing Age. Curr Osteoporos Rep. 2018;16(5): 561-572.
[18] Park H, Noh AL, Kang JH, Sim JS, Lee DS, Yim M. Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3. Antioxid Redox Signal. 2015;22(1): 63-77.
[19] Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484): 1508-1514.
[20] Takeshita S, Kaji K, Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res. 2000;15(8): 1477-1488.
[21] Udagawa N, Koide M, Nakamura M, Nakamichi Y, Yamashita T, Uehara S, et al. Osteoclast differentiation by RANKL and OPG signaling pathways. J Bone Miner Metab. 2021;39(1): 19-26.
[22] Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004;428(6984): 758-763.
[23] Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937): 337-342.
[24] Manolagas SC, O'Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9(12): 699-712.
[25] Gustafsson KL, Nilsson KH, Farman HH, Andersson A, Lionikaite V, Henning P, et al. ERα expression in T lymphocytes is dispensable for estrogenic effects in bone. J Endocrinol. 2018;238(2): 129-136.
[26] Stucker S, Chen J, Watt FE, Kusumbe AP. Bone Angiogenesis and Vascular Niche Remodeling in Stress, Aging, and Diseases. Front Cell Dev Biol. 2020;8: 602269-602289.
[27] Xiong Q, Zhang L, Zhan S, Ge W, Tang P. Investigation of proteome changes in osteoclastogenesis in low serum culture system using quantitative proteomics. Proteome Sci. 2016;14(8):1-13.
[28] Sarkar MK, Sil PC. Hepatocytes are protected by herb Phyllanthus niruri protein isolate against thioacetamide toxicity. Pathophysiology. 2007;14(2): 113-120.
[29] Kang JS, Wanibuchi H, Morimura K, Wongpoomchai R, Chusiri Y, Gonzalez FJ, et al. Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity. Toxicol Appl Pharmacol. 2008;228(3): 295-300.
[30] Győri DS, Mócsai A. Osteoclast Signal Transduction During Bone Metastasis Formation. Front Cell Dev Biol. 2020;8: 507-522.
[31] Mozar A, Haren N, Chasseraud M, Louvet L, Mazière C, Wattel A, et al. High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells. J Cell Physiol. 2008;215(1): 47-54.
[32] Ma Y, Ran D, Zhao H, Song R, Zou H, Gu J, et al. Cadmium exposure triggers osteoporosis in duck via P2X7/PI3K/AKT-mediated osteoblast and osteoclast differentiation. Sci Total Environ. 2021;750: 141638-141649.
[33] Ma Y, Ran D, Cao Y, Zhao H, Song R, Zou H, et al. The effect of P2X7 on cadmium-induced osteoporosis in mice. J Hazard Mater. 2021;405(26): 124251-124263.
[34] Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci. 2008;1143: 123-150.
[35] Jin H, Wang Q, Chen K, Xu K, Pan H, Chu F, et al. Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis. J Cell Mol Med. 2019;23(12): 8355-8368.
[36] Mandal CC, Ghosh Choudhury G, Ghosh-Choudhury N. Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. Endocrinology. 2009;150(11): 4989-4998.
[37] Zhao Y, Xu Y, Zheng H, Lin N. QingYan Formula extracts protect against postmenopausal osteoporosis in ovariectomized rat model via active ER-dependent MEK/ERK and PI3K/Akt signal pathways. J Ethnopharmacol. 2020;29: 113644-113656.
[38] Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;4(7): 552-565.
[39] Tsukamoto H. Development of new palladium (0)-catalyzed reactions based on novel oxidative addition mode. Yakugaku Zasshi. 2008;128(9): 1259-1266.
[40] Durmusoglu EG, Selopal GS, Mohammadnezhad M, Zhang H, Dagtepe P, Barba D, et al. Low-Cost, Air-Processed Quantum Dot Solar Cells via Diffusion-Controlled Synthesis. ACS Appl Mater Interfaces. 2020;12(32): 36301-36310.
[41] Jin Z, Liu Y, Hao X. Self-assembly of zinc cadmium sulfide nanorods into nanoflowers with enhanced photocatalytic hydrogen production activity. J Colloid Interface Sci. 2020;567: 357-368.
[42] Hedlu nd JK, Estrada TG, Walker AV. Chemical Bath Deposition of Copper Sulfide on Functionalized SAMs: An Unusual Selectivity Mechanism. Langmuir. 2020;36(12): 3119-3126.